Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Androgen receptor (Homo sapiens (Human)) | BDBM50170576 (1-(4-{1-[4-(2,3-Dihydroxy-propylamino)-3-methyl-ph...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 1.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosterone | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50131270 (2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]prop...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG PC cid PC sid UniChem Patents Similars | DrugBank PubMed | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Binding affinity against GST-hARLBD was measured in SC-3 cell by using [3H]-testosterone as radioligand | Bioorg Med Chem Lett 13: 2655-8 (2003) BindingDB Entry DOI: 10.7270/Q26D5SDD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50170573 (3-(4-{1-Ethyl-1-[4-(2-hydroxy-3,3-dimethyl-butoxy)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 1.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosterone | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50170578 (1-(4-{1-Ethyl-1-[4-(3-hydroxy-3-methyl-butylamino)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosterone | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50170582 (4-(4-{1-Ethyl-1-[4-(3-hydroxy-3-methyl-butylamino)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 3.38E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosterone | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vitamin D3 receptor (Gallus gallus) | BDBM50145539 ((2S,4R)-2,4-Dihydroxy-6-[2-[(R)-1-((R)-5-hydroxy-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Tokyo Curated by ChEMBL | Assay Description In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1 | Bioorg Med Chem Lett 14: 2579-83 (2004) Article DOI: 10.1016/j.bmcl.2004.02.076 BindingDB Entry DOI: 10.7270/Q20C4V6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 1 (Ovis aries (Sheep)) | BDBM50088679 (2-Phenyl-isoindole-1,3-dione | 2-phenyl-1H-isoindo...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 2 (Ovis aries (Sheep)) | BDBM50088679 (2-Phenyl-isoindole-1,3-dione | 2-phenyl-1H-isoindo...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 2 (Ovis aries (Sheep)) | BDBM50066441 (2-(2,6-Dimethyl-phenyl)-isoindole-1,3-dione | 2-(2...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 1 (Ovis aries (Sheep)) | BDBM50219329 (CHEMBL8968) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 1 (Ovis aries (Sheep)) | BDBM50066441 (2-(2,6-Dimethyl-phenyl)-isoindole-1,3-dione | 2-(2...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 2 (Ovis aries (Sheep)) | BDBM50219329 (CHEMBL8968) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vitamin D3 receptor (Gallus gallus) | BDBM50145538 ((S)-1-Benzyl-5-((R)-2-{(R)-4-[2-[(3S,5R)-3,5-dihyd...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Tokyo Curated by ChEMBL | Assay Description In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1 | Bioorg Med Chem Lett 14: 2579-83 (2004) Article DOI: 10.1016/j.bmcl.2004.02.076 BindingDB Entry DOI: 10.7270/Q20C4V6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Mus musculus) | BDBM50170576 (1-(4-{1-[4-(2,3-Dihydroxy-propylamino)-3-methyl-ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 7.60 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferation | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Mus musculus) | BDBM50170573 (3-(4-{1-Ethyl-1-[4-(2-hydroxy-3,3-dimethyl-butoxy)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferation | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152041 (US8987473, 122) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vitamin D3 receptor (Gallus gallus) | BDBM50145540 ((S)-5-((R)-2-{(R)-4-[2-[(3S,5R)-3,5-Dihydroxy-2-me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Tokyo Curated by ChEMBL | Assay Description In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1 | Bioorg Med Chem Lett 14: 2579-83 (2004) Article DOI: 10.1016/j.bmcl.2004.02.076 BindingDB Entry DOI: 10.7270/Q20C4V6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152051 (US8987473, 137) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostaglandin G/H synthase 2 (Ovis aries (Sheep)) | BDBM50111216 (5-Amino-2-((R)-3-methyl-2,6-dioxo-piperidin-3-yl)-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirin | Bioorg Med Chem Lett 12: 1043-6 (2002) BindingDB Entry DOI: 10.7270/Q28K78D9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152048 (US8987473, 134) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152079 (US8987473, 183) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152017 (US8987473, 82) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152047 (US8987473, 133) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152080 (US8987473, 185) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152026 (US8987473, 97) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152016 (US8987473, 80) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Mus musculus) | BDBM50329704 ((R)-3-(4-(3-(4-((R)-2-hydroxy-3,3-dimethylbutoxy)-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Tokyo Curated by ChEMBL | Assay Description Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferation | Bioorg Med Chem Lett 15: 4327-31 (2005) Article DOI: 10.1016/j.bmcl.2005.06.044 BindingDB Entry DOI: 10.7270/Q2SX6CS6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152011 (US8987473, 64) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152049 (US8987473, 135) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152023 (US8987473, 89) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152015 (US8987473, 78) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152054 (US8987473, 140) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152058 (US8987473, 145) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152020 (US8987473, 86) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vitamin D3 receptor (Gallus gallus) | BDBM50404242 (CHEMBL2114211) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Tokyo Curated by ChEMBL | Assay Description In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1 | Bioorg Med Chem Lett 14: 2579-83 (2004) Article DOI: 10.1016/j.bmcl.2004.02.076 BindingDB Entry DOI: 10.7270/Q20C4V6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152013 (US8987473, 68) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152042 (US8987473, 124) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152050 (US8987473, 136) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152056 (US8987473, 143) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152040 (US8987473, 121) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152027 (US8987473, 99) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152057 (US8987473, 144) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152024 (US8987473, 91) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152010 (US8987473, 61) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152061 (US8987473, 148) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152055 (US8987473, 142) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vitamin D3 receptor (Gallus gallus) | BDBM50404243 (CHEMBL2114212 | CHEMBL3350688) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Tokyo Curated by ChEMBL | Assay Description In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1 | Bioorg Med Chem Lett 14: 2579-83 (2004) Article DOI: 10.1016/j.bmcl.2004.02.076 BindingDB Entry DOI: 10.7270/Q20C4V6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152078 (US8987473, 182) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152073 (US8987473, 171) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM152028 (US8987473, 102) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Sato Pharmaceutical Co., Ltd. US Patent | Assay Description It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result... | US Patent US8987473 (2015) BindingDB Entry DOI: 10.7270/Q23F4NCB | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 174 total ) | Next | Last >> |